Making Strides in the Treatment of Small Cell Lung Cancer.
March 25, 2024
Small cell lung cancer (SCLC) stands as a formidable and aggressive subtype of lung cancer, notorious for its rapid growth and propensity to metastasize early. Accounting for nearly 15% of all lung cancer cases, SCLC is characterized by its quick progression, often spreading to distant organs by the time of diagnosis. This cancer type’s aggressive nature requires clinical research to identify potential treatment modalities for patients with the disease. ASTRIDE is a Phase 3 clinical trial for the treatment of extensive stage SCLC.
For Additional Information:
ClinicalTrials.gov ID NCT05468489
PROMOTED
Celebrate Mother’s Day with The Balancing Act’s exclusive guide, dedicated to creating a day just as special as the moms in our lives. Dive into a treasure trove of activities, delectable recipes, and thoughtful gift ideas curated to make this Mother’s Day an unforgettable celebration of love and appreciation.
PROMOTED
Today's show includes advanced oral care, poverty educational resources, delicious Thai food, funeral planning, and so much more
PROMOTED
Parikh Law Group was founded in 2010 to provide solid, experienced, and affordable representation.
